Corporate News 24-Nov-23
Gland Pharma's Pashamylaram unit clears USFDA inspection
Gland Pharma has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection of its Pashamylaram facility in Hyderabad.
Previous News
Gland Pharma spurts after Hyderabad facility gets EIR from USFDA
( Hot Pursuit - 24-Nov-23 10:58 )
Volumes jump at Gland Pharma Ltd counter
( Hot Pursuit - 23-May-24 11:00 )
Gland Pharma to hold AGM
( Corporate News - 23-May-24 09:38 )
Gland Pharma's Pashamylaram unit clears USFDA inspection
( Corporate News - 24-Nov-23 10:34 )
Board of Gland Pharma recommends final dividend
( Corporate News - 23-May-24 09:38 )
Gland Pharma gains as Q4 PAT soars to Rs 192 cr
( Hot Pursuit - 23-May-24 11:42 )
Gland Pharma announces board meeting date
( Corporate News - 18-Oct-23 12:10 )
Gland Pharma rallies on USFDA nod for breast cancer drug
( Hot Pursuit - 08-Apr-24 13:18 )
Volumes soar at Axis Bank Ltd counter
( Hot Pursuit - 09-Apr-24 11:00 )
Gland Pharma consolidated net profit declines 15.30% in the June 2023 quarter
( Results - Announcements 07-Aug-23 18:19 )
Gland Pharma standalone net profit declines 18.25% in the June 2023 quarter
( Results - Announcements 07-Aug-23 18:19 )
Other Stories
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Akme Fintrade (India) to announce Quarterly Result
03-Jul-24 17:43
Back
Top
